Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in India
N
Updated:
Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in India
Nimisham EditorialSenior Editorial Lead
Nimisham
Source Attribution: View original report on Economic Times